<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Decreasing Pattern Worksheets</title><link>http://www.bing.com:80/search?q=Decreasing+Pattern+Worksheets</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Decreasing Pattern Worksheets</title><link>http://www.bing.com:80/search?q=Decreasing+Pattern+Worksheets</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Primary Myelofibrosis-Related Renal Disorders Treated with a Janus ...</title><link>https://pmc.ncbi.nlm.nih.gov/articles/PMC7879319/</link><description>Extramedullary hematopoiesis is widely known to occur in patients with primary myelofibrosis (PMF). Autopsy studies on individuals with PMF revealed that extramedullary hematopoiesis occurred in the kidneys in 35% of the cases, but there is little awareness regarding such lesions.</description><pubDate>Tue, 18 Feb 2025 20:59:00 GMT</pubDate></item><item><title>(PDF) Renal complications of primary myelofibrosis - ResearchGate</title><link>https://www.researchgate.net/publication/326158701_Renal_complications_of_primary_myelofibrosis</link><description>Recent evidence suggests that renal dysfunction may be a direct consequence of primary myelofibrosis (PMF).</description><pubDate>Tue, 17 Oct 2023 17:18:00 GMT</pubDate></item><item><title>Spectrum of Kidney Biopsy Findings in a Patient with Primary ...</title><link>https://www.sciencedirect.com/science/article/pii/S2468024925006527</link><description>This case underscores the importance of renal biopsy in evaluating unexplained kidney dysfunction in hematologic malignancies and contributes to the expanding recognition of CMRS as a clinicopathologic entity.</description><pubDate>Sat, 25 Oct 2025 07:57:00 GMT</pubDate></item><item><title>Spectrum of Kidney Biopsy Findings in a Patient With Primary Myelofibrosis</title><link>https://www.kireports.org/article/S2468-0249%2825%2900652-7/fulltext</link><description>This case underscores the importance of renal biopsy in evaluating unexplained kidney dysfunction in hematologic malignancies and contributes to the expanding recognition of CM of renal significance as a clinicopathologic entity.</description><pubDate>Wed, 22 Apr 2026 05:58:00 GMT</pubDate></item><item><title>Myelofibrosis Prognosis - Rare Disease Advisor</title><link>https://www.rarediseaseadvisor.com/disease-info-pages/myelofibrosis-prognosis/</link><description>Myelofibrosis (MF) involves the clonal proliferation of hematopoietic stem cells in the bone marrow, which leads to cytokine release and bone marrow fibrosis. The prognosis or disease course may vary among patients with MF.</description><pubDate>Mon, 20 Apr 2026 15:54:00 GMT</pubDate></item><item><title>American Journal of Hematology - Wiley Online Library</title><link>https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.26857</link><description>Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations; additional features include bone marrow reticulin/collagen fibrosis, aberrant inflammatory cytokine expression, anemia, hepatosplenomegaly ...</description><pubDate>Mon, 06 Apr 2026 23:35:00 GMT</pubDate></item><item><title>How I treat myelofibrosis - American Society of Hematology</title><link>https://ashpublications.org/blood/article/124/17/2635/33251/How-I-treat-myelofibrosis</link><description>To improve current therapeutic results, the combination of JAK inhibitors with other agents is currently being tested, and newer drugs are being investigated.</description><pubDate>Mon, 06 Apr 2026 22:45:00 GMT</pubDate></item><item><title>Myelofibrosis Progression: Signs, Factors, and Outcomes</title><link>https://biologyinsights.com/myelofibrosis-progression-signs-factors-and-outcomes/</link><description>One serious outcome is the transformation to acute myeloid leukemia (AML), an aggressive and rapidly progressing blood cancer. This transformation occurs in 10% to 20% of myelofibrosis patients over 10 years.</description><pubDate>Sat, 25 Apr 2026 09:22:00 GMT</pubDate></item><item><title>Primary Myelofibrosis-Related Renal Disorders Treated with a Janus ...</title><link>https://karger.com/cnd/article/11/1/1/68285/Primary-Myelofibrosis-Related-Renal-Disorders</link><description>Based on these findings, the pathologist diagnosed the patient with interstitial nephritis as the primarily cause of kidney dysfunction. However, because of the large number of cells with nuclear atypia in the stroma, we suspected renal extramedullary hematopoiesis.</description><pubDate>Wed, 11 Mar 2026 09:32:00 GMT</pubDate></item><item><title>Myelofibrosis – MPN Research Foundation</title><link>https://mpnresearchfoundation.org/primary-myelofibrosis-pmf/</link><description>People living with myelofibrosis (MF) and other myeloproliferative neoplasms (MPNs) deserve clear, accurate information they can trust to understand their diagnosis, symptoms, and treatment options.</description><pubDate>Sat, 04 Apr 2026 04:24:00 GMT</pubDate></item></channel></rss>